ResearchSite 

 
Print Friendly Version Help and Support
  Research Home

TVO Available Technology Abstracts

Directions: Click the icon above to create a version for printing.




Scansite: A World-Wide-Web Interfaced Bioinformatic Computer Program to Predict Sites of Protein-Protein Interaction and Protein Phosphorylation (BIDMC 245)

Category:    Bioinformatics

KeyWords:  

BIDMC ID:    245

Abstract:

Beth Israel Deaconess Medical Center has available for licensing a novel bioinformatics software program called Scansite. Developed by Lewis Cantley, Ph.D., and his colleagues in the BIDMC Signal Transduction lab, Scansite is a world-wide web interfaced bioinformatic computer program to predict sites of protein-protein interaction and protein phosphorylation. The program allows scientists to scan a protein sequence for novel functions, interactions, and post-translational modifications. Application is not limited to proteins previously identified in the lab, but can also deduce this information for theoretical proteins whose sequences are obtained from the Human Genome Project or other sequencing initiatives.

Inventor:   Lewis Cantley, Ph.D. et al.

Commercial Opportunity:


Competitive Advantages:


Related Publications:


State of Development:


Related Technology URL:


Patent Status:

US Patent Application filed on April 23, 1999.

TVO Contact Info:
     Jason S Felsch
     Senior Licensing Manager, TVO
     jfelsch@bidmc.harvard.edu
     Phone: 617-667-9490   Fax: 617-667-0646

     Beth Israel Deaconess Medical Center
     Technology Ventures Office  Room: BR-202
     330 Brookline Avenue
     Boston, MA 02215



 

Copyright 2009 Beth Israel Deaconess Medical Center | Contact Research Webmaster

IP Address: 38.107.191.81   |  Web Server: research.bidmc.harvard.edu   |  Database Server: Colorado\SQL17   |  App Path: /tvo/tvotech.asp   |  Version:

Browser: CCBot/1.0 (+http://www.commoncrawl.org/bot.html)
SecurityGroup: